Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP146705.RAlKT-0Exi7NxoQoDf7mO4NETXigbJAzlI5omJiXV902I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP146705.RAlKT-0Exi7NxoQoDf7mO4NETXigbJAzlI5omJiXV902I130_assertion type Assertion NP146705.RAlKT-0Exi7NxoQoDf7mO4NETXigbJAzlI5omJiXV902I130_head.
- NP146705.RAlKT-0Exi7NxoQoDf7mO4NETXigbJAzlI5omJiXV902I130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP146705.RAlKT-0Exi7NxoQoDf7mO4NETXigbJAzlI5omJiXV902I130_provenance.
- NP146705.RAlKT-0Exi7NxoQoDf7mO4NETXigbJAzlI5omJiXV902I130_assertion evidence source_evidence_literature NP146705.RAlKT-0Exi7NxoQoDf7mO4NETXigbJAzlI5omJiXV902I130_provenance.
- NP146705.RAlKT-0Exi7NxoQoDf7mO4NETXigbJAzlI5omJiXV902I130_assertion SIO_000772 19420352 NP146705.RAlKT-0Exi7NxoQoDf7mO4NETXigbJAzlI5omJiXV902I130_provenance.
- NP146705.RAlKT-0Exi7NxoQoDf7mO4NETXigbJAzlI5omJiXV902I130_assertion wasDerivedFrom gad-20150221 NP146705.RAlKT-0Exi7NxoQoDf7mO4NETXigbJAzlI5omJiXV902I130_provenance.
- NP146705.RAlKT-0Exi7NxoQoDf7mO4NETXigbJAzlI5omJiXV902I130_assertion wasGeneratedBy ECO_0000203 NP146705.RAlKT-0Exi7NxoQoDf7mO4NETXigbJAzlI5omJiXV902I130_provenance.